Bird fancier's lung

Summary

Bird fancier’s lung (MONDO:0005668) is a disease and 2 clinical trials. A subtype of hypersensitivity pneumonitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	bird fancier’s lung
Mondo ID	MONDO:0005668
MeSH	D001716
Orphanet	99908
DOID	DOID:13891
ICD-10-CM	J67.2
ICD-11	912113736
NCIT	C34425
SNOMED CT	69339004
UMLS	C0005592
MedGen	586
GARD	0016924
MedDRA	10004941
Is cancer (heuristic)	no

Also known as: Avian hypersensitivity pneumonitis · bird fancier lung · bird fancier’s lung · bird-fanciers’ lung · pigeon-breeder lung disease · pigeon-breeder’s lung

Disease family

This is a subtype of hypersensitivity pneumonitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › allergic respiratory disease › hypersensitivity pneumonitis › bird fancier’s lung

Related subtypes (13): ventilation pneumonitis, bagassosis, farmer’s lung disease, malt worker’s lung, cork-handlers’ disease, maple bark strippers’ lung, mushroom workers’ lung, sick building syndrome, hypersensitivity pneumonitis, familial, idiopathic chronic eosinophilic pneumonia, house allergic alveolitis, non-fibrotic hypersensitivity pneumonitis, fibrotic hypersensitivity pneumonitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03056404	Not specified	COMPLETED	Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier’s Lung
NCT03747627	Not specified	COMPLETED	BPF Genetics of ILD Study